Risk of recurrent venous thromboembolism in cancer patients after discontinuation of anticoagulant therapy
Submitted: 2 February 2024
Accepted: 24 February 2024
Published: 16 May 2024
Accepted: 24 February 2024
Abstract Views: 241
PDF: 131
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.